{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T08:40:19Z","timestamp":1785487219224,"version":"3.56.0"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The aim of the study was to determine the prevalence of rare disease-causing variants in cardiomyopathy-associated genes in a cohort of patients with ischemic and non-ischemic dilated cardiomyopathy undergoing heart transplant.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a single-center cohort study of 60 adult patients with left ventricular ejection fraction \u226450% and left ventricular end-diastolic dimension \u226595th percentile for sex\/height who underwent heart transplant between January 2017 and December 2023 and consented to participate in a cardiac tissue biobank. We evaluated the prevalence of rare (minor allele frequency &amp;lt;0.1%) disease-causing (pathogenic or likely pathogenic by American College of Genetics and Genomics criteria) variants in cardiomyopathy-associated genes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 60 individuals fulfilled the inclusion criteria: 16 with ischemic dilated cardiomyopathy [88% men, median age 65\u2005years, interquartile range (IQR) 64\u201368\u2005years] and 44 with non-ischemic dilated cardiomyopathy (80% men, median age 53\u2005years, IQR 39\u201365\u2005years). We found that the prevalence of disease-causing variants was similar between patients with ischemic dilated cardiomyopathy (3\/16 or 19%; 95% credible interval 6%\u201336%) and those with non-ischemic dilated cardiomyopathy (10\/44 or 23%; 95% credible interval 12%\u201333%). Variants in the ischemic dilated cardiomyopathy group were found in the <jats:italic>TTN<\/jats:italic> and <jats:italic>DMD<\/jats:italic> genes. Variants in the non-ischemic dilated cardiomyopathy group were found in the <jats:italic>TTN<\/jats:italic>, <jats:italic>FLNC<\/jats:italic>, <jats:italic>LMNA<\/jats:italic>, <jats:italic>MYH7<\/jats:italic>, and <jats:italic>RBM20<\/jats:italic> genes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Patients with ischemic dilated cardiomyopathy undergoing heart transplant possessed a similar burden of rare disease-causing variants as those with non-ischemic dilated cardiomyopathy. Our results suggest that genetic testing may be beneficial in patients with advanced heart failure requiring heart transplant due to ischemic dilated cardiomyopathy to detect disease-causing variants in cardiomyopathy-associated genes.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2025.1542653","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T05:24:05Z","timestamp":1745904245000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Similar burden of rare genetic variants in ischemic and non-ischemic dilated cardiomyopathy"],"prefix":"10.3389","volume":"12","author":[{"given":"Louie","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Rushakoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Karlstaedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Kittleson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Czer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan P.","family":"Kransdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.healun.2019.08.004","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-sixth adult heart transplantation report - 2019; focus theme: donor and recipient size match","volume":"38","author":"Khush","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"B2","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/S0735-1097(01)01738-7","article-title":"A standardized definition of ischemic cardiomyopathy for use in clinical research","volume":"39","author":"Felker","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e001826","DOI":"10.1161\/CIRCGENETICS.117.001826","article-title":"Toward genetics-driven early intervention in dilated cardiomyopathy: design and implementation of the DCM precision medicine study","volume":"10","author":"Kinnamon","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1093\/eurheartj\/ehr064","article-title":"Relationship between location and size of myocardial infarction and their reciprocal influences on post-infarction left ventricular remodelling","volume":"32","author":"Masci","year":"2011","journal-title":"Eur Heart J"},{"key":"B5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/ehjci\/jez165","article-title":"Determinants and prognostic value of cardiac magnetic resonance imaging-derived infarct characteristics in non-ST-elevation myocardial infarction","volume":"21","author":"Feistritzer","year":"2020","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"B6","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1161\/CIRCGEN.120.003031","article-title":"Implications of genetic testing in dilated cardiomyopathy","volume":"13","author":"Verdonschot","year":"2020","journal-title":"Circ Genom Precis Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1001\/jama.2023.11970","article-title":"Genetic architecture of dilated cardiomyopathy in individuals of African and European ancestry","volume":"330","author":"Jordan","year":"2023","journal-title":"JAMA"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.amjcard.2015.06.032","article-title":"Diagnostic accuracy of cardiac magnetic resonance imaging in the evaluation of newly diagnosed heart failure with reduced left ventricular ejection fraction","volume":"116","author":"Won","year":"2015","journal-title":"Am J Cardiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1002\/ejhf.2250","article-title":"Prevalence and clinical outcomes of dystrophin-associated dilated cardiomyopathy without severe skeletal myopathy","volume":"23","author":"Restrepo-Cordoba","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"B10","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1161\/CIRCGEN.123.004221","article-title":"DMD-associated dilated cardiomyopathy: genotypes, phenotypes, and phenocopies","volume":"16","author":"Johnson","year":"2023","journal-title":"Circ Genom Precis Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e002480","DOI":"10.1161\/CIRCGEN.119.002480","article-title":"Variant interpretation for dilated cardiomyopathy: refinement of the American college of medical genetics and genomics\/ClinGen guidelines for the DCM precision medicine study","volume":"13","author":"Morales","year":"2020","journal-title":"Circ Genom Precis Med"},{"key":"B12","article-title":"R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria","year":"2023"},{"key":"B13","article-title":"pwrss: Statistical Power and Sample Size Calculation Tools. R package version 0.3.1","author":"Bulus","year":"2023"},{"key":"B14","article-title":"BayesFactor: Computation of Bayes Factors for Common Designs. R package version 0.9","author":"Morey","year":"2023"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.21105\/joss.01541","article-title":"Describing effects and their uncertainty, existence and significance within the Bayesian framework","volume":"4","author":"Makowski","year":"2019","journal-title":"J Open Source Softw"},{"key":"B16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/ejhf.3033","article-title":"Assessing the association between genetic and phenotypic features of dilated cardiomyopathy and outcome in patients with coronary artery disease","volume":"26","author":"Jones","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"B17","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1161\/CIRCULATIONAHA.123.067032","article-title":"Nonischemic or dual cardiomyopathy in patients with coronary artery disease","volume":"149","author":"Bawaskar","year":"2024","journal-title":"Circulation"},{"key":"B18","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1001\/jamacardio.2020.6500","article-title":"Assessing the role of rare genetic variation in patients with heart failure","volume":"6","author":"Povysil","year":"2021","journal-title":"JAMA Cardiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/s41436-018-0039-z","article-title":"Genetic evaluation of cardiomyopathy: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)","volume":"20","author":"Hershberger","year":"2018","journal-title":"Genet Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1056\/NEJMoa1100356","article-title":"Coronary-artery bypass surgery in patients with left ventricular dysfunction","volume":"364","author":"Velazquez","year":"2011","journal-title":"N Engl J Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1056\/NEJMoa2206606","article-title":"Percutaneous revascularization for ischemic left ventricular dysfunction","volume":"387","author":"Perera","year":"2022","journal-title":"N Engl J Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1002\/ejhf.2911","article-title":"Coronary revascularization for heart failure with coronary artery disease: a systematic review and meta-analysis of randomized trials","volume":"25","author":"Iaconelli","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"B23","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/ejhf.3463","article-title":"Revascularization and outcomes in ischaemic left ventricular dysfunction after heart failure admission: the RevascHeart study","volume":"27","author":"Moliner-Abos","year":"2025","journal-title":"Eur J Heart Fail"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1542653\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T05:24:07Z","timestamp":1745904247000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1542653\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":23,"alternative-id":["10.3389\/fcvm.2025.1542653"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1542653","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"article-number":"1542653"}}